| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* To whom correspondence should be addressed. E-mail: eberhard.nieschlag{at}ukmuenster.de.
The goal of hormonal male contraception is the reversible suppression of spermatogenesis to a level compatible with infertility. Using testosterone alone or testosterone in combination with a gestagen or a GnRH-antagonist has been successful in lowering sperm counts in semen to azoospermia or to severe oligozoospermia in multiple studies. This document is a novel effort by researchers and physicians to draft new recommendations for testing and regulatory approval of hormonal contraceptive products for men.
Key words: Sperm
Spermatogenesis
This article has been cited by other articles:
![]() |
S. T. Page, J. K. Amory, and W. J. Bremner Advances in Male Contraception Endocr. Rev., June 1, 2008; 29(4): 465 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Handelsman Update in Andrology J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4505 - 4511. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |